Literature DB >> 3676279

Phosphatidylinositol anchor of HeLa cell alkaline phosphatase.

R Jemmerson1, M G Low.   

Abstract

Alkaline phosphatase from cancer cells, HeLa TCRC-1, was biosynthetically labeled with either 3H-fatty acids or [3H]ethanolamine as analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fluorography of immunoprecipitated material. Phosphatidylinositol-specific phospholipase C (PI-PLC) released a substantial proportion of the 3H-fatty acid label from immunoaffinity-purified alkaline phosphatase but had no effect on the radioactivity of [3H]ethanolamine-labeled material. PI-PLC also liberated catalytically active alkaline phosphatase from viable cells, and this could be selectively blocked by monoclonal antibodies to alkaline phosphatase. However, the alkaline phosphatase released from 3H-fatty acid labeled cells by PI-PLC was not radioactive. By contrast, treatment with bromelain removed both the 3H-fatty acid and the [3H]ethanolamine label from the purified alkaline phosphatase. Subtilisin was also able to remove the [3H]ethanolamine-labeled from purified alkaline phosphatase. The 3H radioactivity in alkaline phosphatase purified from [3H]ethanolamine-labeled cells comigrated with authentic [3H]ethanolamine by anion-exchange chromatography after acid hydrolysis. The data suggest that the 3H-fatty acid and [3H]ethanolamine are covalently attached to the carboxyl-terminal segment since bromelain and subtilisin both release alkaline phosphatase from the membrane by cleavage at that end of the polypeptide chain. The data are consistent with findings for other proteins recently shown to be anchored in the membrane through a glycosylphosphatidylinositol structure and indicate that a similar structure contributes to the membrane anchoring of alkaline phosphatase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3676279     DOI: 10.1021/bi00392a019

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  5'-Nucleotidases of chicken gizzard and human pancreatic adenocarcinoma cells are anchored to the plasma membrane via a phosphatidylinositol-glycan.

Authors:  U Stochaj; K Flocke; W Mathes; H G Mannherz
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Processing at the carboxyl terminus of nascent placental alkaline phosphatase in a cell-free system: evidence for specific cleavage of a signal peptide.

Authors:  C A Bailey; L Gerber; A D Howard; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  Biosynthesis of glycosylphosphatidylinositol-anchored human placental alkaline phosphatase: evidence for a phospholipase C-sensitive precursor and its post-attachment conversion into a phospholipase C-resistant form.

Authors:  Y W Wong; M G Low
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

4.  A new mechanism of dominance in hypophosphatasia: the mutated protein can disturb the cell localization of the wild-type protein.

Authors:  A S Lia-Baldini; I Brun-Heath; C Carrion; B Simon-Bouy; J L Serre; M E Nunes; E Mornet
Journal:  Hum Genet       Date:  2008-03-14       Impact factor: 4.132

5.  Erv26p-dependent export of alkaline phosphatase from the ER requires lumenal domain recognition.

Authors:  Julia Dancourt; Charles Barlowe
Journal:  Traffic       Date:  2009-04-29       Impact factor: 6.215

6.  Transport of 9-(2-phosphonomethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediated.

Authors:  T Cihlár; I Rosenberg; I Votruba; A Holý
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

7.  Structure of the glycosylphosphatidylinositol membrane anchor of human placental alkaline phosphatase.

Authors:  C A Redman; J E Thomas-Oates; S Ogata; Y Ikehara; M A Ferguson
Journal:  Biochem J       Date:  1994-09-15       Impact factor: 3.857

8.  Aspartic acid-484 of nascent placental alkaline phosphatase condenses with a phosphatidylinositol glycan to become the carboxyl terminus of the mature enzyme.

Authors:  R Micanovic; C A Bailey; L Brink; L Gerber; Y C Pan; J D Hulmes; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

9.  Prosthetic rehabilitation of hypophosphatasia: a case report.

Authors:  Bora Bağiş; Esra Baltacioğlu; Elif Aydoğan; Evşen Tamam
Journal:  Cases J       Date:  2008-12-12

10.  Mild forms of hypophosphatasia mostly result from dominant negative effect of severe alleles or from compound heterozygosity for severe and moderate alleles.

Authors:  Delphine Fauvert; Isabelle Brun-Heath; Anne-Sophie Lia-Baldini; Linda Bellazi; Agnès Taillandier; Jean-Louis Serre; Philippe de Mazancourt; Etienne Mornet
Journal:  BMC Med Genet       Date:  2009-06-06       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.